Session 2 Panel Discussion (Laboratory Management and Statistical Analysis Plans for Clinical Nutrition Studies)

Speaker(s)

• KB

  Kathryn Barger, PhD

  Senior Statistician
  JM USDA HNRCA at Tufts University
  Boston, Massachusetts, United States

  Disclosure: Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
• 

  Kevin C. Maki, PhD

  President and Chief Scientist
  Midwest Biomedical Research
  Addison, Illinois, United States

  Disclosure: Disclosure(s): Acasti Pharma Inc.: Consultant (Ongoing)
  Beren Therapeutics: Consultant (Ongoing)
  Eli Lilly and Co.: Consultant (Ongoing)
  Naturmega: Grant/Research Support (Ongoing)
  New Amsterdam Pharma: Consultant (Ongoing)
  NorthSea Therapeutics: Consultant (Ongoing)
  Novo Nordisk Pharma Inc.: Consultant (Ongoing)
  Pharmavite: Grant/Research Support (Ongoing)
• GM

  George P. McCabe, PhD

  Emeritus Professor, Department of Statistics
  Purdue University
  West Lafayette, Indiana, United States

  Disclosure: Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
• 

  Joshua W. Miller, PhD (he/him/his)

  Professor & Chair of Nutritional Sciences
  Department of Nutritional Sciences, Rutgers University
  New Brunswick, New Jersey, United States

  Disclosure: Disclosure(s): Church & Dwight Co.: Consultant (Terminated); Independent Contractor (including contracted research) (Terminated)
• 

  Connie M. Weaver, PhD (she/her/hers)

  Distinguished Professor of Research
  San Diego State University
  San Diego, California, United States

  Disclosure: Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.